Evidence- and Experience-Based Therapeutic Profiles for Il-6 Inhibition: A Review of Landmark Trials, Clinical Experience, and Improvements In Disease Activity Resulting From Targeted Inhibition of the Il-6 Signaling System In Patients With RA - Professor Mark C. Genovese, MD – Program Chair Professor of Medicine Co-Chief, Division of Immunology and Rheumatology Stanford University